| Synonyms | Bavdegalutamide |
|---|
| CAS No. | 2222112-77-6 |
|---|
| Purity | >99% |
|---|
| Formula | C41H43ClFN9O6 |
|---|
| Mol Weight | 812.288 |
|---|
| Color | Light yellow to yellow |
|---|
| State | solid powder |
|---|
| Solubility | Soluble in DMSO 26.67 mg/mL |
|---|
| Shelf Life | >2 years if stored properly |
|---|
| Storage | Powder -20°C, sealed storage, away from moisture; In solvent -20℃ 1 month; |
|---|
| Shipping | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
|---|
| |
|---|
| | |
|---|
| Reference: | [1]. Neklesa T, et al. ARV-110: An oral androgen receptor PROTAC degrader for prostate cancer. Journal of Clinical Oncology. Journal of Clinical Oncology March 1 2019 37(7_suppl):259.
[2]. Zeng S, et al. Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges. Eur J Med Chem. 2021 Jan 15;210:112981. doi: 10.1016/j.ejmech.2020.112981. Epub 2020 Oct 31. PMID: 33160761.
[3]. Wang Y, et al. Degradation of proteins by PROTACs and other strategies. Acta Pharm Sin B. 2020 Feb;10(2):207-238. doi: 10.1016/j.apsb.2019.08.001. Epub 2019 Aug 13. PMID: 32082969; PMCID: PMC7016280. |
|---|
| Data Sheet | Data sheet of ARV-110 |
|---|
| CoA | CoA of ARV-110 |
|---|
Inhibitor Specialist 
